daratumumab
janssen
['daratumumab']
join us today at 2022 to hear from , and dr. bhatla on initial findings from the delphinus study of daratumumab in pediatric and young adult patients with relapsed/refractory t-cell all or ll. #asco22 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.